Historical record - last NADAC effective date: 2/22/2017

Product Information

QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5361 per EA under NDC 65862016230. Its NADAC has been published 170 times since Nov 28, 2013.

FDA first approved this application on Aug 24, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB

QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE
$0.5361per EA

Strength

12.5; 20 mg/1; mg/1

NDC

65862016230

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

2/22/2017

Approval Type

Generic (ANDA)

FDA Application

ANDA078450

FDA Approved

8/24/2007

TE Code

AB

On Market Since

8/24/2007

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5361 per EA
All-time high$0.6584 (Mar 16, 2016)
All-time low$0.4823 (Jun 22, 2016)
Median price$0.5503
Average price$0.5586
Largest weekly change+23.0% (Feb 17, 2016)
Weeks tracked170
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-10.7%

Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.5361 per EA (NDC 65862016230), effective Feb 22, 2017.

How has the price of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 10.7%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

Since Nov 28, 2013, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.4823 (Jun 22, 2016) to a high of $0.6584 (Mar 16, 2016), with a median of $0.5503 per EA.

Are there cheaper alternatives to QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, is $0.3606 per EA — about 33% below QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB.

Who manufactures QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

QUINAPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 65862016230) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.